Moderna and AstraZeneca’s mRNA therapy for heart regeneration passes Phase I safety test
Wednesday, February 20, 2019 - 07:50
in Health & Medicine
The clinical data is the first testing mRNA for therapeutic protein production
The clinical data is the first testing mRNA for therapeutic protein production